San Diego-centered Viking Therapeutics marked by itself as a serious competitor inside the weight loss drug industry in February soon after revealing promising info from a mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when provided to be a weekly injection and in March the company unv